Emerging themes from the literature on circulating biomarkers of traumatic brain injury. (May 2015)

• Record Type: Journal Article
• Authors: Paziana, Karolina; Korley, Frederick K
• Is Part Of: Future neurology. Volume 10:Number 3(2015)
• Page Start: 281
• Page End: 291
• Publication Date: 2015-05
• Subjects: biomarker -- brain-derived neurotrophic factor -- cleaved Tau -- glial fibrillary acidic protein -- MRNA -- myelin-based protein -- neuron specific enolase -- S100B -- spectrin breakdown product -- traumatic brain injury -- ubiquitin C-terminal hydrolase-L1; Neurology -- Research -- Periodicals; 611.8005
• DOI: 10.2217/fnl.15.13
• Languages: English
• ISSNs: 1479-6708

Abstract

ABSTRACT : Objective diagnosis of traumatic brain injury (TBI) and early prediction of TBI-associated outcome remains a significant clinical challenge with major public health implications. The use of circulating biomarkers to quantify TBI has promise for real-time clinical decision making and may help clinicians determine the need for advanced imaging, and guide an individualized approach to the management of TBI. In this review of the literature, we provide an overview of candidate TBI biomarkers and discuss several themes emerging from the literature on TBI biomarkers. We suggest that the future utility of TBI biomarkers lies in the creation of composite panels of biomarkers tailored to the pursuit of specific clinic questions.